Drug comparisons
Acarbose vs Ertugliflozin
Acarbose vs Ertugliflozin: Precose delays carbs for T2DM postprandial vs Steglatro SGLT2 glucosuria. No boxed warning preg B vs YES boxed warning.
No comparison dimensions are available for this page.
Clinical context
This comparison arises for patients with type 2 diabetes considering an alpha-glucosidase inhibitor versus an SGLT2 inhibitor.
Bottom line
Acarbose provides postprandial control with GI effects and no boxed warning while Ertugliflozin offers glucosuria benefits with a boxed warning.
All medication comparisons